← All trials
NCT03057561
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2016
- Primary completion
- Sep 30, 2018
- Completion date
- Sep 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- The Methodist Hospital SystemLead sponsor
- GuerbetCollaborator
- Methodist Cancer Center, Houston, TexasOverall official - principal investigator
- Methodist Cancer Center, Houston, TexasSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.